Rupali Sawant

Rupali Sawant

Auto-generated profile, based on publicly available information

Rupali Sawant

Department of Head and Neck Surgery Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust Liverpool UK

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
RSR. Sawant
R. Sawant
KHK. Hulse
K. Hulse
SSS. Sohrabi
S. Sohrabi
JYJ.C.L. Yeo
J.C.L. Yeo
KPK. Pal
K. Pal
INIain Nixon
Iain Nixon
The oncological benefit of completion thyroidectomy (CT) following thyroid lobectomy (TL) is presumed to be similar to that of upfront total thyroidectomy(TT), from a patient's perspective the risk and inconvenience of further surgery adds significantly to the impact of the overall treatment. The aim of this study is to assess the impact of CT in terms of the duration of admission and associated complications. A study of consecutive patients with DTC identified from prospective MDT records of South-East Scotland from 2009 to 2015. Surgical data was extracted from electronic medical record. Of 361 patients diagnosed with DTC, 161 (45%) had CT. The median postoperative stay was 1 day (range 1-5days). In total 22 patients (14%)suffered complications. Four patients (3%) developed postoperative haematoma. Two (1%) had an identified permanent nerve palsy on the completion side. 13 patients (8%) remained on calcium supplementation for more than 6 months postoperatively and three patients (2%) developed wound complications. Our study confirms that CT is regularly performed (45%). Recent changes in international guidelines recognize increasing number of patients as eligible for a conservative approach but recommend CT based on whether upfront TT would have been recommended if the TL pathology were known from the outset. Such an approach fails to consider the additional risk and inconvenience of CT on the overall patient experience. Due to a relatively high rate of complications, only those patients who are most likely to benefit from further surgery to facilitate adjuvant radioactive iodine should be offered additional surgery.

4 July 2018 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
VPVinidh Paleri
Vinidh Paleri
RSRupali Sawant
Rupali Sawant
HMHisham Mehanna
Hisham Mehanna
HAHolly Ainsworth
Holly Ainsworth
DSDeborah Stocken
Deborah Stocken

1 December 2021 in The Surgeon
Verified
Journal Article
Closed access
RSR. Sawant
R. Sawant
AFA. FitzGerald
A. FitzGerald
SHSy. Hey
Sy. Hey
KHK. Hulse
K. Hulse
AHA. Hay
A. Hay
INIain Nixon
Iain Nixon

21 December 2020 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
RSR. Sawant
R. Sawant
SHS.Y. Hey
S.Y. Hey
KHK. Hulse
K. Hulse
AHA. Hay
A. Hay
FGF.W. Gibb
F.W. Gibb
INIain Nixon
Iain Nixon

22 March 2022
Verified
Book Chapter
Closed access
PDF file
ADAnushka Devale
Anushka Devale
RSRupali Sawant
Rupali Sawant
KPKarishma Pardesi
Karishma Pardesi
SSSurekha Satpute
Surekha Satpute
SMShilpa Mujumdar
Shilpa Mujumdar
Petroleum is one of the globally used energy sources by mankind. The uncontrolled mining and petroleum usage have led to rampant environmental pollution. The petroleum and its hydrocarbons are extremely toxic to the ecosystem as well as human health. Hence, there is a prerequisite to develop an alternative economic “Green Technology” to the current physicochemical processes in order to reduce the toxic impacts on global living systems. Bioremediation is a wise and widespread approach to tackle pollutants of the environment. However, practically it appears to be challenging, when the contaminants of concern are hydrocarbons which are complex and their insolubility in the aqueous phase is evident. Remediation of environmental pollutants has been accomplished through assimilation, mineralization and biotransformation processes. Therefore, approaches based on the bioremediation process are certainly effective and trustworthy. Biosurfactants, being of biological origin are less toxic and are undeniably advantageous over chemical means for the purpose of remediation. From the huge world of biosurfactants; rhamnolipids appear to be the major attraction of the global market. Rhamnolipids are anionic type surface-active glycolipids consisting of rhamnose and β-hydroxyalkanoic acid units produced by different species of Pseudomonas. Rhamnolipids are used in agriculture mainly as biocontrol agents and in bioremediation processes. Although there is high demand for rhamnolipids, several challenges are associated with its applicability in fields. Among them, the two major challenges are the requirements of huge monetary inputs for the production of biosurfactants and the pathogenic nature of biosurfactant producing organisms. Therefore, lots of efforts are being made to design safe and cost-effective methodologies to produce rhamnolipids. This chapter summarizes the applications and challenges involved in rhamnolipid assisted hydrocarbon soil bioremediation.

8 October 2026 in Clinical Otolaryngology
Verified
Journal Article
Open access
MRMatthew E. Ryan
Matthew E. Ryan
MZMatthew Zammit
Matthew Zammit
KMKristijonas Milinis
Kristijonas Milinis
OAOmar Ahmed
Omar Ahmed
RSRupali Sawant
Rupali Sawant
JFJason Fleming
Jason Fleming
Objectives: To report early outcomes following implementation of a da Vinci Single‐Port transoral robotic surgery (SP‐TORS) programme in the United Kingdom. To provide contextual benchmarking, outcomes were compared with a historical institutional cohort treated using transoral laser microsurgery (TLM). Design: Retrospective institutional series with comparison against a historical cohort using stabilised inverse‐probability‐of‐treatment weighting. Setting: High‐volume UK Tertiary Head and Neck Centre. Participants: All patients undergoing SP‐TORS between April 2024 and September 2025. Comparative analyses were limited to oncological resections and included 33 SP‐TORS and 61 TLM cases. Main Outcome Measures: Feasibility, peri‐operative safety, postoperative haemorrhage, return to theatre, mortality, length of stay, time to oral diet, margin status and adjuvant therapy use. Results: Sixty‐six patients underwent SP‐TORS. All procedures were completed transorally without unplanned conversion or peri‐operative mortality. Postoperative haemorrhage occurred in 4.5%, with one return to theatre. Length of stay did not differ between groups. Time to oral diet was longer following SP‐TORS (adjusted ratio 1.51, p = 0.005). ASCO‐defined involved margins were similar (OR 0.30, 95% CI 0.06–1.56; p = 0.15), whereas specimen ink‐positive margins were less frequent following SP‐TORS (OR 0.31, 95% CI 0.11–0.91; p = 0.03). A sensitivity analysis using propensity‐matched T1/T2 pairs demonstrated a consistent directional effect, though this did not reach significance in the smaller matched cohort. Adjuvant therapy use was comparable. Conclusion: SP‐TORS implementation in a high‐volume UK centre was feasible and safe during early adoption, with low complication rates. Peri‐operative and early functional outcomes were broadly comparable with TLM. Although specimen ink‐positive margins were less frequent following SP‐TORS, interpretation should be cautious given the historical comparator and associated differences in departmental workflow. These findings support safe integration of SP‐TORS into transoral surgical practice and justify prospective evaluation.